Daily pill for weight loss in adults with overweight or obesity
Part of Hormones & metabolism clinical trials.
This trial tests an investigational once-daily pill (ASC30) to see if it can help adults with overweight or obesity lose weight. You may be able to join if you have a high body mass index (BMI) and have tried to lose weight before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- Your BMI is 30 or higher, or your BMI is 27 or higher and you have a weight-related condition like high blood pressure, high cholesterol, sleep apnea, or heart disease.
- You have tried to lose weight before, even if it didn't work well.
- You have not been diagnosed with diabetes (type 1 or type 2) and have not had diabetic ketoacidosis.
- Your weight has been stable (no more than 11 pounds or 5 kg change) in the last 3 months.
- You have not had pancreatitis and have no history of a certain type of thyroid cancer in you or a close family member.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral medication, ASC30, to see if it helps people with type 2 diabetes who are overweight or obese lose weight and improve blood sugar control. It is a once-daily pill that may offer a new treatment option.
This study tests a new daily pill (aleniglipron) to help adults with excess weight and type 2 diabetes lose weight and improve blood sugar control. It may be a good fit if you have a BMI of 27 or higher and your diabetes is managed with A1c between 6.5% and 10%.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
This trial tests an investigational drug called BI 3034701 to see if it helps people lose weight. It is for adults who are obese or overweight with at least one weight-related health problem.
This trial tests a daily pill called KAI-7535 to see if it helps people with obesity or overweight lose weight safely. It is for adults who have a body mass index (BMI) of 27 or higher and at least one weight-related health problem, such as high blood pressure or type 2 diabetes.
This clinical trial tests new treatments for adults who are overweight or have obesity. The goal is to help people lose weight and improve their health.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.